Effects of sitagliptin on gastric emptying in healthy subjects

Trial Profile

Effects of sitagliptin on gastric emptying in healthy subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 03 Nov 2015

At a glance

  • Drugs Sitagliptin (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 28 Jun 2012 Results published in the Alimentary Pharmacology and Therapeutics.
    • 22 Aug 2011 Planned end date changed from 1 Nov 2009 to 1 Dec 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top